Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA GMP Warning Letters Review: Compounding Pharmacies Drew The Most Letters In 2016

Apr 28 2017

• By Bowman Cox

2016 Drug GMP Warning Letters By Facility Type, Day 4

Related Content

Drug Compounder Acquitted Of Murder In Fungal Meningitis Outbreak Case

Mar 23 2017

FDA’s 2016 Drug GMP Warning Letters

Apr 25 2017

FDA GMP Warning Letters Review: Rate Soared In 2016 On Sterility And Data Integrity Concerns

Apr 25 2017

FY 2015 Drug GMP Warning Letters Hit Compounders and Foreign Sites

Jan 29 2016

FDA Backs Off From Early Citations Of Compounder Sterility Issues

Jul 14 2016

Additional Topics

United States Manufacturing Quality Compliance BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window